Taking tirzepatide: the decisions that shape how it works for you

Deciding when and where to inject, and why consistency matters

The injection itself takes less than a minute. What takes thought is building a routine that sticks. Most people choose the same day each week; moving it by up to two days either side is acceptable, but erratic timing can make side effects feel less predictable. Many people pick a weekend morning before anything else is on (before the kettle goes on, before children are up) because it becomes automatic rather than something to remember mid-afternoon.

Site choice is abdomen, thigh or upper arm. Rotation matters: using the same spot repeatedly can cause localised skin thickening that affects how the medicine absorbs. Clean the skin first, let the area dry, then press the pen firmly until you hear the click. The NHS tirzepatide guidance covers the injection technique in plain language and is worth reading before your first dose.

Storage is non-negotiable: Mounjaro pens are refrigerated at 2–8°C. Each pen covers four weekly doses. For precise guidance on any limited room-temperature window (relevant if you are travelling) the Mounjaro Patient Information Leaflet is the definitive source; if in doubt, ask your prescriber. Our guide to taking Mounjaro goes deeper on the practical technique side.

Reading the early weeks: what is a side effect, what is a sign to act on

For most people, the first few weeks of taking tirzepatide involve some digestive adjustment. Nausea is the most reported complaint; constipation, loose stools, belching and indigestion are all common. These are not a sign the medicine is not working. They are your gut responding to slower gastric emptying, and they typically settle once your body adapts, usually within a week or two of starting or after a dose step.

Practical approaches that many people find useful: eating smaller portions and more slowly, avoiding high-fat meals in the first weeks, staying well hydrated. Our guidance on what to keep in mind when taking tirzepatide covers these supportive habits in more detail, though your prescriber is the right person to adjust if symptoms persist.

There are symptoms that warrant prompt medical attention rather than waiting. Severe, persistent stomach pain that radiates to the back (with or without vomiting) can be a sign of pancreatitis, a known but uncommon risk with GLP-1 medicines flagged in the MHRA's January 2026 Drug Safety Update. Gallbladder symptoms, signs of a serious allergic reaction, or heavy vomiting that causes dehydration all require urgent assessment. If you are unsure at any point, contact your prescriber, at nume that means reaching our clinical team, available seven days a week.

The dose titration decision: patience versus pushing

One of the most common questions prescribers field is whether to stay longer at a lower dose or move up quickly. There is no single right answer; it depends on how you are tolerating each step and how your weight is responding. The licensed schedule works upward from 2.5 mg in four-week steps, 2.5 mg is a tolerability stage, not the active dose, and most clinical results come at higher doses over months of treatment.

Titrating faster than four-week steps to chase a quicker result typically increases gastrointestinal side effects without meaningfully improving outcomes. If you are already in treatment and want a clear overview of what to expect at each stage, our page for people who are currently taking Mounjaro covers what good progress looks like and when to flag concerns. A good prescriber balances both signals. At nume, our clinical team reviews every repeat before it is issued, not as a box-tick, but to check that your current dose is still appropriate and that there are no emerging concerns to address.

If you want to understand what the broader tirzepatide evidence shows about long-term results at different doses, the tirzepatide overview page covers the trial data in detail.

Cost, continuity and what to think about before starting

Taking tirzepatide is a medium-to-long-term commitment. The medicine works while you are on it; stopping abruptly without a plan (dietary or otherwise) is associated with weight regaining. That is not a reason to avoid it, but it is a reason to think about sustainability from the start: can you access a consistent supply, and is the cost manageable over months rather than weeks?

Eli Lilly raised Mounjaro's UK list price from 1 September 2025, and private market prices since then have ranged roughly £149–£375 per month depending on dose and provider. For context on what that includes (or does not) from different services, the Mounjaro prices page breaks down what a legitimate private prescription should cover. The short version: a quoted price that excludes the consultation, prescription and clinical aftercare is not really a comparable price.

Before you start, your prescriber should know your full medication list. Women taking oral contraceptives need particular attention: MHRA guidance notes that tirzepatide may reduce pill absorption, so an additional non-oral method is recommended for the first four weeks of treatment and for four weeks after each dose increase. HRT users should discuss with their prescriber whether a transdermal form is more appropriate while taking tirzepatide. These are not obscure edge cases, they are questions that come up frequently, and they matter. It is also worth reading our advice on what happens after taking Mounjaro, so you understand what to expect once a dose has been administered. If you are ready to start, a free consultation with one of our prescribers is the first step.